Executive Summary
Across 20 NASDAQ-100 related SEC filings from March 25, 2026, key themes include robust capital returns via dividends and buybacks (e.g., Century Communities $178.4M dividends + $144M repurchases, Adobe $2.48B buybacks), mixed financial performance with standout growth in homebuilding (Century rev $4.1B) and software (Adobe +12% YoY rev to $6.4B) offset by biotech declines (Dyadic -12% rev, wider losses) and banking stress (TCBS NPAs +316% to 2.65%). Leadership transitions dominate tech and funds (Adobe CEO search, TXN SVP retirement, Muzinich dual entities CEO/CFO changes effective Apr 1), signaling potential continuity risks but no disagreements noted. Period-over-period trends show YoY revenue growth averaging +7% in highlighted firms (Adobe +12%, Century strong units), but asset/loan quality deterioration in banks (TCBS assets -3% YoY, deposits -2%). Capital allocation leans shareholder-friendly with steady dividends (Dime $0.25, CMC $0.20), while debt actions (Micron tenders, OneMeta $2.2M notes maturing Mar 26) and SPAC stasis (Axiom no combo) add liquidity nuances. Portfolio implications favor overweighting growth outperformers like Adobe/Century amid sector rotation from stressed small caps.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from March 24, 2026.
Investment Signals(12)
- Century Communities↓(BULLISH)▲
2025 rev $4.1B, NI $147.6M ($4.86 EPS), book value +5% YoY to $89.21, 10,792 units delivered, $178.4M dividends + $144M buybacks, costs down $13k/home, debt ratio 25.9%
- Adobe↓(BULLISH)▲
Q1 FY26 rev +12% YoY to $6.4B (subscription +13%), NI +4% to $1.89B ($4.60 EPS), op cash flow +19% to $2.96B, $2.48B buybacks QoQ
- Dime Community Bancshares↓(BULLISH)▲
Quarterly div $0.25/share payable Apr 24 (rec Apr 17), signaling sustained payout capacity
- Commercial Metals (CMC)(BULLISH)▲
Quarterly div $0.20/share payable Apr 15 (rec Apr 6), consistent capital return
- PayPal↓(BULLISH)▲
Added Alyssa Henry (ex-Square CEO) to board, replacing retiring Gail McGovern, enhancing payments expertise with 11/12 independent directors
- AITX(BULLISH)▲
RAD expansion orders from global logistics leader, positive momentum in AI deployments
- Century Communities↓(BULLISH)▲
Net new contracts 10,326, 60,916 lot pipeline, 94% affordable homes, exec comp down 30%
- Acadia Healthcare↓(BULLISH)▲
New CEO Debra Osteen effective Jan 20, 2026, strong board attendance (100% at AGM), all audit experts independent
- Axiom Intelligence Acquisition↓(BULLISH)▲
Net income $3.65M from $4.23M interest on $204M trust, assets $205M despite no business combo
- Texas Community Bancshares (TCBS)(BULLISH)▲
NI $2.84M (vs 2024 loss $1.3M), NII +6% to $13.3M, NIM expands to 3.26%, capital ratio +107 bps to 16.67%
- Dyadic International↓(BULLISH)▲
Cash $8.59M supports pipeline (AlbuFree, DNase I launches, new agreements), grant rev +$1.86M despite rev dip
- Adobe↓(BULLISH)▲
Cash +17% QoQ to $6.33B, total assets stable ~$29.7B, subscription segments +12-16% YoY
Risk Flags(10)
- Dyadic International/Losses↓[HIGH RISK]▼
FY25 rev -12% YoY to $3.09M, net loss widens to $7.36M (-$0.23 EPS from -$0.20), op loss +22% to $7.19M, cash down to $8.59M
- Texas Community Bancshares/Asset Quality↓[HIGH RISK]▼
NPAs +316% YoY to $11.4M (2.65% of assets), OREO +$9.3M from foreclosures, provision for losses +426% to $831k, assets -3% YoY
- OneMeta/Debt Maturity↓[HIGH RISK]▼
$2.2M notes consolidate (orig $2M + $0.2M add'l) mature Mar 26, 2026 or default, MFN clause for future terms
- Adobe/Leadership↓[MEDIUM RISK]▼
CEO Shantanu Narayen transitioning (notified Mar 9), successor search underway, remains Chair until appointed
- Dyadic International/Risks↓[MEDIUM RISK]▼
History of losses, customer concentration, capital needs, no dividends expected, stock volatility
- Texas Instruments/Executive Departure↓[MEDIUM RISK]▼
SVP Hagop Kozanian retires Aug 31, 2026, no successor named
- Axiom Intelligence/SPAC Delay↓[MEDIUM RISK]▼
No business combination since Jan 2025 inception, shareholders' deficit -$7.18M, potential $1.5M working capital loans
- Muzinich Entities/Leadership Churn[MEDIUM RISK]▼
CEO Youle, CFO Fehre step down Apr 1, 2026 (stay on board), new execs from Muzinich despite no disagreements
- Century Communities/Proxy↓[LOW RISK]▼
Reduced exec comp (Exec Chair STI -30%), board refreshment amid challenging environment
- Micron/Debt Refinancing↓[LOW RISK]▼
Tender offers for multiple senior notes (2031-2035), potential liquidity strain
Opportunities(10)
- Century Communities/AGM & Pipeline↓(OPPORTUNITY)◆
Record returns $322.8M total, 60k lot pipeline, costs -1.4% (~$13k/home), vote on directors/auditor/say-on-pay May 6, 2026
- Adobe/Growth Momentum↓(OPPORTUNITY)◆
Subscription rev +13% YoY ($6.2B), Creative +12%, Business +16%, op cash +19%, undervalued vs growth post-CEO transition
- Dyadic International/Earnings Call↓(OPPORTUNITY)◆
Commercial launches (Proliant, Fermbox), new deals (IBT, BRIG, Inzymes), call Mar 25, 2026 5pm ET for guidance
- PayPal/Board Refresh↓(OPPORTUNITY)◆
New high-profile director Alyssa Henry bolsters scaling expertise in 200 markets
- Dime & CMC/Dividends(OPPORTUNITY)◆
Reliable yields, Dime $0.25 (Apr 24), CMC $0.20 (Apr 15), attractive in rate environment
- TCBS/Turnaround(OPPORTUNITY)◆
Profitable swing to $2.84M NI, NIM 3.26%, CRE loans +10% to 20% portfolio despite NPA spike
- AITX/Expansion(OPPORTUNITY)◆
RAD orders from major logistics client, AI tech momentum
- Acadia Healthcare/Governance↓(OPPORTUNITY)◆
CEO transition complete, nomination window Jan-Feb 2027, strong compliance
- Micron/Tender Offers↓(OPPORTUNITY)◆
Refinance 5.3-6.05% notes due 2031-35, potential yield curve play
- Axiom/SPAC Trust Yield↓(OPPORTUNITY)◆
2% interest yield on $204M trust, watch for AI/intel combo
Sector Themes(6)
- Capital Returns Resilience◆
5/20 filings highlight dividends/buybacks (Century $322M total, Adobe $2.48B, Dime/CMC quarterly), averaging steady payouts amid mixed earnings, supports defensive portfolios [IMPLICATION: Favor yield names in volatility]
- Leadership Transitions Cluster◆
7/20 show exec changes (Adobe CEO, TXN SVP, Muzinich dual CEO/CFO Apr 1, Acadia CEO Jan), no disagreements but continuity risks in tech/funds [IMPLICATION: Monitor successor impacts on strategy]
- Mixed Banking Stress◆
TCBS assets -3% YoY, deposits -2%, NPAs +316% but NIM +20 bps to 3.26%; contrasts dividend stability [IMPLICATION: Selective overweight on capital-strong regionals]
- Growth Outliers in Software/Homebuilding◆
Adobe +12% rev YoY, Century book +5%/$4.1B rev vs Dyadic -12%, avg +7% in growth names [IMPLICATION: Rotate to rev/margin leaders]
- Biotech/SPAC Stasis◆
Dyadic losses widen, Axiom no combo (trust yield 2%), cash burn risks [IMPLICATION: Avoid until catalysts]
- Debt Actions Rising◆
Micron tenders, OneMeta $2.2M notes Mar 26 maturity, signals liquidity mgmt in semis/fintech [IMPLICATION: Watch refinancing costs]
Watch List(8)
FY25 results discussion, pipeline updates, guidance on launches Mar 25, 2026 5pm ET
Director elections, say-on-pay, auditor ratification May 6, 2026 (rec Mar 9)
Virtual meeting Apr 15, 2026 9am PT, successor appointment timeline post-Mar 9 notice
$0.25/share ex-date post-Apr 17, monitor payout sustainability
$0.20/share Apr 6 close, quarterly trend continuity
$2.2M repayment/conversion Mar 26, 2026, MFN clause activation
- Muzinich Entities/Leadership👁
New CEO Rivkin et al. effective Apr 1, 2026, execution post-transition
Successor to Hagop Kozanian by Aug 31, 2026, ops impact
Filing Analyses(20)
25-03-2026
Century Communities, Inc. reported strong 2025 financial performance with $4.1B in total revenues, $147.6M net income ($4.86 per diluted share), and a record book value per share of $89.21 (+5% YoY), while delivering 10,792 residential units and returning a record $178.4M to stockholders via dividends and $144M in repurchases despite a challenging environment. Operationally, net new contracts reached 10,326 with a 60,916 lot pipeline, and 94% of deliveries were affordable homes below FHA limits. The proxy seeks approval for director elections, auditor ratification, and say-on-pay, highlighting governance enhancements like reduced executive compensation (e.g., Exec Chairman target STI down 30% from 2024) and board refreshment.
- ·Annual meeting scheduled for May 6, 2026 at 1:00 p.m. MT, Hyatt Regency Denver Tech Center, Denver, CO; record date March 9, 2026.
- ·Net homebuilding debt to net capital ratio: 25.9% as of 2025.
- ·Direct construction costs on starts declined by average $13,000 per home in 2025.
- ·Board governance: 5/7 directors independent (>70%), annual elections, majority vote standard, hedging/pledging prohibitions.
- ·Engaged top stockholders representing 78% of shares in 2025.
25-03-2026
Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on March 25, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release titled 'AITX's RAD Inks Continued Expansion Orders from Global Logistics Leader.' The press release, attached as Exhibit 99.1, highlights ongoing business expansion with a major client, signaling positive momentum in RAD deployments.
- ·Filed with SEC on March 25, 2026; Date of earliest event: March 25, 2026
- ·Registrant details: Nevada incorporation, CIK 0001498148, EIN 27-2343603, principal offices at 10800 Galaxie Avenue, Ferndale, Michigan 48220
- ·Information furnished under Item 8.01, not deemed 'filed' or subject to Section 18 liabilities
25-03-2026
Century Communities, Inc. (CCS) filed a Definitive Additional Proxy Statement (DEFA14A) on March 25, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing includes standard company data such as CIK 0001576940, EIN 680521411, fiscal year end December 31, and headquarters at 8390 E. Crescent Pkwy., Suite 650, Greenwood Village, CO 80111. No substantive proposals, financial metrics, or voting details are discernible in the provided content, which primarily consists of metadata and apparent graphical or encoded image data.
- ·Standard Industrial Classification: Operative Builders [1531]
- ·State of Incorporation: Delaware
- ·SEC File Number: 001-36491
- ·Business Phone: 303.770.8300
25-03-2026
Hagop Kozanian, Senior Vice President of Texas Instruments Incorporated (TXN), announced his intention to retire effective August 31, 2026, as disclosed in an 8-K filing on March 25, 2026. The filing was signed by Katharine Kane, Senior Vice President, Secretary and General Counsel. No information on a successor or any financial impact was provided.
- ·Company headquarters: 12500 TI Boulevard, Dallas, Texas 75243
- ·Registrant’s telephone number: (214) 479-3773
- ·Common Stock, par value $1.00, trading symbol TXN on The Nasdaq Global Select Market
25-03-2026
Canadian Pacific Kansas City Limited filed its 2026 Notice of Annual Meeting of Shareholders and 2026 Management Proxy Circular (dated March 10, 2026) with Canadian securities regulatory authorities on March 25, 2026, and attached it as Exhibit 99.1 to this Form 8-K. The company also filed the Notice of Availability of Materials for the 2026 Annual Meeting (Exhibit 99.2) and issued a press release announcing these filings (Exhibit 99.3). This filing satisfies U.S. reporting requirements as a foreign private issuer using domestic forms.
- ·Principal executive offices: 7550 Ogden Dale Road S.E., Calgary, Alberta, Canada, T2C 4X9
- ·Securities registered: Common Shares (CP on NYSE and TSX); Perpetual 4% Consolidated Debenture Stock (CP40 on NYSE, BC87 on London Stock Exchange)
25-03-2026
Dyadic International reported 2025 full-year revenue of $3.09 million, down 12% YoY from $3.50 million, primarily due to lower research and development ($0.97M vs $1.61M) and license/milestone revenue ($0.27M vs $1.89M), despite a $1.86 million increase in grant revenue. Net loss widened to $7.36 million or $(0.23) per share from $5.81 million or $(0.20) per share, with operating loss increasing to $7.19 million from $5.90 million, though cash position stood at $8.59 million (down from $9.29 million). The company highlighted progress with commercial launches including AlbuFree™ DX by Proliant, DNase I with Fermbox Bio, and agreements with IBT Bioservices, BRIG Bio, and Inzymes, positioning for future revenue streams.
- ·Research and development revenue: $967,311 in 2025 vs $1,605,220 in 2024.
- ·Cost of research and development revenue: $600,700 in 2025 vs $1,194,624 in 2024.
- ·Earnings call scheduled for March 25, 2026 at 5:00 p.m. ET.
- ·CRISPR/Cas9 non-exclusive license agreement with ERS Genomics signed.
- ·AdaptVac (CEPI-supported): $12.4 million filovirus vaccine program.
- ·European Vaccines Hub (EVH): €170 million EU-backed initiative.
25-03-2026
Dyadic International Inc. (DYAI) filed its 10-K annual report on March 25, 2026, detailing extensive business and financial risks, including a history of net losses, dependency on a small number of customers, need for substantial additional capital, competitive pressures, and potential failure to commercialize technologies. The company highlights risks from international operations, key personnel loss, cybersecurity, and product liability, with no expectation of paying cash dividends. While advancing the Dapibus™ platform through engineering new strains, improving genetic tools, and optimizing processes for commercial applications, the filing emphasizes volatility in stock price and operating results without providing specific financial metrics.
25-03-2026
Acadia Healthcare's proxy statement outlines its board committee compositions and activities in 2025, with the Board holding 12 meetings and all directors attending 75% or more, while the Audit and Risk Committee held 8 meetings, Nominating Committee 3, and Compliance Committee 5; however, the Finance Committee did not meet. It details governance practices, including director nomination procedures with deadlines for the 2027 annual meeting between January 6 and February 5, 2027, and notes leadership changes with Debra K. Osteen appointed CEO effective January 20, 2026, succeeding Christopher H. Hunter. All audit committee members qualify as financial experts and meet independence requirements.
- ·All 2025 annual meeting directors attended in person.
- ·Audit committee members Bissell, Cancelmi, Fucci, Grieco, and Kelly are audit committee financial experts and independent.
- ·Stockholder director nominations for 2027 annual meeting must be delivered between close of business January 6, 2027 and February 5, 2027.
- ·Board has no formal policy separating CEO and Chairman roles but currently separates them.
25-03-2026
PayPal Holdings, Inc. announced that Alyssa Henry, former CEO of Block’s Square business, has joined the Board of Directors, praised for her extensive experience in scaling payments and technology platforms. Gail J. McGovern, a board member since 2015, will retire and not stand for re-election at the upcoming Annual Meeting of Stockholders in May. The board will now consist of 12 directors, 11 independent, with Ann Sarnoff succeeding McGovern as chair of the Corporate Governance and Nominating Committee.
- ·Gail J. McGovern served on the Board since 2015
- ·PayPal empowers consumers and businesses in approximately 200 markets
25-03-2026
Acadia Healthcare Company, Inc. (ACHC) filed a DEFA14A Definitive Additional Materials proxy statement on March 25, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific financial data, proposals, or other substantive details are included in the provided filing header.
- ·Filing Type: DEFA14A (Schedule 14A Information)
- ·Filed by the Registrant
25-03-2026
Axiom Intelligence Acquisition Corp 1, a blank check company, reported total assets of $205,155,188 as of December 31, 2025, primarily driven by $204,234,694 in the Trust Account from its IPO proceeds. For the period from inception (January 30, 2025) through December 31, 2025, it recorded net income of $3,649,620, fueled by $4,234,694 in interest income, but offset by a $585,074 operating loss from general and administrative expenses and a shareholders' deficit of $7,184,280. No Business Combination has been completed, with risks including potential foreign operations post-combination and up to $1,500,000 in convertible Working Capital Loans.
- ·Cash: $736,280; Prepaid expenses: $135,431; Total Current Assets: $871,711
- ·Current Liabilities: $104,774 (Accrued offering costs $75,000; Accrued expenses $29,774)
- ·Long-term prepaid insurance: $48,783
- ·Net income per share: $0.20 (basic and diluted for both Redeemable and Non-redeemable shares)
- ·Weighted average shares: 11,582,090 (Redeemable Class A); 6,663,383 / 6,862,388 (Non-redeemable Class A and B)
25-03-2026
Commercial Metals Company (CMC) declared a regular quarterly cash dividend of $0.20 per share of common stock on March 25, 2026. The dividend is payable on April 15, 2026, to stockholders of record as of the close of business on April 6, 2026. No comparative dividend amounts or changes from prior quarters were disclosed.
25-03-2026
On March 25, 2026, Micron Technology, Inc. commenced cash tender offers to purchase any and all of its outstanding senior notes, including 5.300% Senior Notes due 2031, 5.650% Senior Notes due 2032, 5.875% Senior Notes due 2033 (two series), 5.800% Senior Notes due 2035, and 6.050% Senior Notes due 2035. The press release detailing the offers is attached as Exhibit 99.1.
- ·Common Stock: par value $0.10 per share, trading symbol MU on Nasdaq Global Select Market
- ·Principal executive offices: 8000 South Federal Way, Boise, Idaho 83716-9632
- ·Registrant’s telephone number: (208) 368-4000
25-03-2026
On March 17, 2026, OneMeta Inc. entered into a First Amendment to its October 31, 2025 Note and Warrant Purchase Agreement, consolidating $2M in Existing Notes with $0.2M Additional Notes issued on February 11, 2026, into a single $2.2M principal amount with maturity on the earlier of March 26, 2026 or an Event of Default. Noteholders can elect repayment in cash, common stock at the conversion price, or new preferred stock at the lowest price paid to unaffiliated third parties. The amendment includes a most-favored-nation clause allowing holders to adopt more favorable terms from any future convertible instruments issued by the Company.
- ·Original Note and Warrant Purchase Agreement dated October 31, 2025
- ·Amended Notes include right to amend for more favorable terms from Future Instruments, exercisable within 30 days of notice
25-03-2026
On March 23, 2026, Muzinich Corporate Lending Income Fund, Inc. announced a leadership transition effective April 1, 2026, with CEO Jeffrey Youle and CFO/Treasurer Paul Fehre stepping down from their executive roles but continuing as Board members and in other capacities at Muzinich & Co., Inc., with no disagreements noted. The Board appointed Cheryl Rivkin as new CEO, Jens Ernberg as President, Rocco DelGuercio as new CFO/Treasurer, and Susan Cohen as Secretary. No related party transactions or arrangements were disclosed.
- ·Former CEO Jeffrey Youle will serve as Senior Adviser at Muzinich; former CFO Paul Fehre as Chief Operating Officer at Muzinich.
- ·Cheryl Rivkin, 56, joined Muzinich in 2003; Jens Ernberg, 56, joined in 2025; Rocco DelGuercio, 62, joined in November 2025; Susan Cohen, 42, joined in 2017.
25-03-2026
Muzinich BDC, Inc. announced on March 23, 2026, a leadership transition effective April 1, 2026, with President and CEO Jeffrey Youle and CFO and Treasurer Paul Fehre stepping down from their executive roles but remaining on the Board; no disagreements were noted. The Board appointed Cheryl Rivkin as new CEO, Jens Ernberg as President, Rocco DelGuercio as CFO and Treasurer, and Susan Cohen as Secretary. All new executives are currently affiliated with Muzinich & Co., Inc.
- ·Departing executives expressed no disagreement on Company operations, policies, or practices.
- ·No arrangements or understandings between new appointees and the Company or other entities requiring disclosure under Item 404(a) of Regulation S-K.
- ·New appointees have prior experience at firms including Capital Dynamics, Credit Suisse, and Investcorp.
25-03-2026
Adobe Inc. filed a supplement to its definitive proxy statement for the 2026 Annual Meeting of Stockholders, disclosing that CEO Shantanu Narayen notified the company on March 9, 2026, of his decision to transition from his CEO role, with Adobe conducting a search for a successor. Mr. Narayen will remain CEO until a successor is appointed and continue as Chair of the Board of Directors. The supplement confirms that voting matters remain unchanged, and previously submitted proxies are valid unless revoked.
- ·Annual Meeting to be held virtually on April 15, 2026 at 9:00 a.m. Pacific Time.
- ·Original Proxy Statement filed with SEC on February 27, 2026.
- ·Stockholders who have already voted do not need to take action unless they wish to change their vote.
25-03-2026
Adobe Inc. reported total revenue of $6,398 million for the three months ended February 27, 2026, up 12% YoY from $5,714 million, primarily driven by subscription revenue growth of 13% to $6,198 million including 12% in Creative & Marketing Professionals ($4,389 million) and 16% in Business Professionals & Consumers ($1,782 million). However, product revenue declined 5% to $90 million, services and other revenue fell 19% to $110 million, and operating expenses increased 13% to $3,316 million. Net income rose 4% YoY to $1,889 million with diluted EPS of $4.60, while operating cash flow improved 19% to $2,958 million amid $2,478 million in common stock repurchases.
- ·Total assets increased slightly to $29,704 million from $29,496 million QoQ.
- ·Stockholders’ equity decreased to $11,433 million from $11,623 million QoQ.
- ·Cash and cash equivalents rose to $6,332 million from $5,431 million QoQ.
- ·Short-term debt increased to $849 million from $0 QoQ; long-term debt decreased to $5,379 million from $6,210 million QoQ.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 20 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)